A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved lung cancer survival rates, according to a new study. This was compared to...
Hundreds of NHS patients are set to benefit from a revolutionary lung cancer drug that targets a genetic mutation dubbed the ‘death star’. Sotorasib targets a...
